CFP
IDXX icon

Catalyst Financial Partners’s Idexx Laboratories IDXX Stock Holding History

Catalyst Financial Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Buy
533
+78
+17% +$50K 0.04% 292
2025
Q4 		$308K Buy
455
+10
+2% +$6.81K 0.03% 244
2025
Q3 		$284K Buy
445
+10
+2% +$6.07K 0.03% 244
2025
Q2 		$233K Buy
+435
New +$208K 0.03% 268

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Catalyst Financial Partners's IDXX Position: Q1 2026 in Review

Catalyst Financial Partners increased its Idexx Laboratories (IDXX) stake by 17% in Q1 2026, buying an estimated $50K and bringing the position to 533 shares worth $299K. The position accounts for 0.04% of the portfolio, ranked #292.

Catalyst Financial Partners first reported a position in IDXX in Q2 2025 and has held it in 4 quarters since. The position peaked at $308K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Catalyst Financial Partners held 533 shares of Idexx Laboratories worth $299K as of Q1 2026.
  • Catalyst Financial Partners bought 78 Idexx Laboratories shares in Q1 2026, an estimated $50K.
  • Idexx Laboratories made up 0.04% of Catalyst Financial Partners's portfolio in Q1 2026, its #292 holding.
  • Catalyst Financial Partners first reported a position in Idexx Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Catalyst Financial Partners's Idexx Laboratories position peaked at $308K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Catalyst Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.